Imaging of pulmonary tuberculosis with 18F-fluoro-deoxy-glucose and 18F-ethylcholine

Open Nuclear Medicine Journal

Volumn 6, Issue 1, 2014, Pages 17-21

  Vorster, M ^a   Stoltz, A ^a   Jacobs, A G ^a   Sathekge, M M ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

18F fluoroethyl choline; 18F FDG; Functional imaging; Lung lesions; PET CT; Sarcoidosis; Tuberculosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUORODEOXYGLUCOSE F 18 FLUOROETHYL CHOLINE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ETHYLCHOLINE F 18; RIFAMPICIN;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FOLLOW UP; FUNCTIONAL NEUROIMAGING; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG LESION; LUNG TUBERCULOSIS; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; BIOPSY; DIFFERENTIAL DIAGNOSIS; GRANULOMATOSIS; HISTOLOGY; LUNG NODULE; MALIGNANT NEOPLASTIC DISEASE; PET-CT SCANNER; PLEURA EFFUSION;

EID: 84923292959     PISSN: None     EISSN: 1876388X     Source Type: Journal    
DOI: 10.2174/1876388X01406010017     Document Type: Article

References (14)

1. Sathekge MM, Maes AA, Pottel HH, Stoltz AA, van de Wiele CC. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area. S Afr Med J 2010; 100(9): 598-601.
2. Ito K, Morooka M, Minamimoto R, Miyata Y, Okasaki M, Kubota K. Imaging spectrum and pitfalls of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with tuberculosis. Jpn J Radiol 2013; 1-10.
3. Cheng G, Torigian DA, Zhuang H, Alavi A. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol Imaging 2013; 40(5): 779-87.
4. Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr 1994; 14: 269-96.
5. DeGrado TR, Baldwin SW, Wang S, et al. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. J Nucl Med. 2001; 42(12): 1805-14.
6. Treglia G, Giovannini E, Di Franco D, et al. The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review. Ann Nucl Med 2012; 26(6): 451-61.
7. Peng ZZ, Liu QQ, Li MM, Han MM, Yao SS, Liu QQ. Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer. Clin Lung Cancer 2012; 13(4): 312-20.
8. Pieterman RM, Que TH, Elsinga PH, et al. Comparison of 11Ccholine and 18F-FDG PET in primary diagnosis and staging of patients with thoracic cancer. J Nucl Med 2002; 43(2): 167-72.
9. Liu Q, Peng Z-M, Liu Q-W, et al. The role of 11C-choline positron emission tomography-computed tomography and videomediastinoscopy in the evaluation of diseases of middle mediastinum. Chin Med J 2006; 119(8): 634-9.
10. Hara T, Inagaki K, Kosaka N, Morita T. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. J Nucl Med 2000; 41(9): 1507-13.
11. Hara T, Kosaka N, Suzuki T, Kudo K, Niino H. Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study. Chest 2003; 124: 893-901.
12. Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging 2004; 31: 1064- 72.
13. Peng Z, Liu Q, Li M, Han M, Yao S, Liu Q. Comparison of (11)Ccholine PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer. Clin Lung Cancer 2011. doi: 10.1016/j.cllc.2011.09.005.
14. Wang T, Sun YE, Yao SL, Yu CH, Yin DY, Tian JH. Value of carbon-11 choline positron emission tomography in patients with pulmonary abnormalities. Zhonghua Wai Ke Za Zhi 2006; 44: 405- 8.